titlesubmit dateissue date
Now showing items 1-4 of 4
Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial.
Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study
Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension.